Autonomize’s AI copilots organize, contextualize and summarize unstructured data to reduce the administrative burden for healthcare knowledge workers to make data-driven decisions and improve patient outcomes. Autonomize AI is a founding member of CancerX, the US President Biden’s Cancer Moonshot initiative. Our customers include Top 20 pharma, F100 Payors and life sciences companies.
autonomize.aiThese are collections Autonomize AI is a part of. Click on the collection name to view similar companies.
Series A
$28,000,000
Seed
$4,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Autonomize AI.